Loading clinical trials...
Loading clinical trials...
Phase II Study of Combination Vorinostat and Bortezomib in Patients With Relapsed and/or Refractory Non-Hodgkin Lymphoma
Conditions
Interventions
Vorinostat in combination with Bortezomib
Start Date
June 1, 2010
Primary Completion Date
May 1, 2012
Completion Date
May 1, 2012
Last Updated
September 19, 2017
NCT06189391
NCT05006716
NCT06026319
NCT05950165
NCT06876662
NCT05755087
Lead Sponsor
The Methodist Hospital Research Institute
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions